CASSADY REMY: Open Payments
NPI 1730726621 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 23 payments from 11 companies in 2025. Trend: 2023 $601 · 2024 $764 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| SOBI, INC | 3 | $79 |
| Azurity Pharmaceuticals, Inc. | 2 | $61 |
| Astellas Pharma US Inc | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $33 |
| Adaptive Biotechnologies Corporation | 1 | $28 |
| PFIZER INC. | 1 | $24 |
Products named: Fabhalta, Vonjo, SCEMBLIX, DANZITEN, Cresemba, Vanflyta, NINLARO, OJJAARA.
Industry payments across OH — which companies pay providers there.
